Saint Ismier, France

Jean-Claude Schulhof


Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1990-1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jean-Claude Schulhof: Innovator in Nucleoside Derivatives

Introduction

Jean-Claude Schulhof is a notable inventor based in Saint Ismier, France. He has made significant contributions to the field of nucleoside derivatives, holding a total of 3 patents. His work focuses on the synthesis of oligonucleotides, which are essential in various biotechnological applications.

Latest Patents

Schulhof's latest patents include innovative derivatives of nucleosides. One of his key inventions relates to the synthesis of oligonucleotides using specific nucleoside derivatives. These derivatives are characterized by a formula where B represents a radical derived from guanine, cytosine, or adenine, with various protective groups and radicals that facilitate the synthesis process. Another significant patent involves N4-(3-phenylproprionyl)-2'-deoxycytidine derivatives, which are particularly useful in oligonucleotide synthesis due to the rapid removal of the 3-phenyl-proprionyl blocking group by ammonia.

Career Highlights

Jean-Claude Schulhof is associated with the Commissariat à l'Énergie Atomique, where he has contributed to groundbreaking research in the field of nucleosides. His work has implications for advancements in genetic research and therapeutic applications.

Collaborations

Throughout his career, Schulhof has collaborated with esteemed colleagues such as Didier Molko and Robert Teoule. These partnerships have further enhanced the impact of his research in the scientific community.

Conclusion

Jean-Claude Schulhof's innovative work in nucleoside derivatives has positioned him as a key figure in the field of biotechnology. His patents reflect a commitment to advancing the synthesis of oligonucleotides, which are vital for future scientific developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…